(BON) Bon Natural Life - Ratings and Ratios

Bon Natural Life Limited (NASDAQ:BON), established in 2006 and headquartered in Xian, China, specializes in the R&D, production, and distribution of natural herb-derived active ingredients. The company serves various industries including functional foods, personal care, cosmetics, and pharmaceuticals by providing ingredients like fragrances and health supplements. Their product portfolio includes bioactive food ingredients and powder drinks used as nutritional supplements and additives.

With a market capitalization of $3.96M, Bon Natural Life exhibits a P/E ratio of 5.58 and a forward P/E of 2.35, indicating potential undervaluation. The price-to-book ratio of 0.09 and price-to-sales ratio of 0.17 further suggest attractive valuations. The return on equity stands at 10.43%, reflecting efficient equity utilization.

Technically, the stocks average 20-day volume is 24,590, with a last price of $0.92. The SMA 20, 50, and 200 are $1.09, $1.34, and $1.75 respectively, while the ATR is $0.14. This data points to a stock trading below its short and long-term moving averages, signaling a bearish trend with low volatility.

Over the next three months, BON is expected to face downward pressure due to being below key moving averages. The low average volume may lead to high volatility. However, the undervalued fundamentals could attract investors seeking bargains, potentially stabilizing or increasing the stock price slightly, albeit with limited upside due to overall market conditions. The stock is likely to trade within a narrow range near current levels, with potential for modest recovery if market sentiment improves.